Company News

Post Acute Medical Deploys Biodefense Indoor Protection System Shown to Kill COVID-19 Virus at Three Hospitals

ENOLA, PA - Post Acute Medical, LLC (PAM) announced today that it has deployed Integrated Viral Protection's (IVP) indoor biodefense system at three of its specialty hospital locations in Las Vegas, Nevada, Victoria, Texas, and San Antonio, Texas as part of the company's commitment to delivering important health services safely.

IVP's game-changing technology is proven to eliminate the airborne transmission of SARS-CoV-2 to control the indoor spread of COVID-19. PAM's hospitals are the very first to proactively install these innovative systems in the fight against COVID-19.

"IVP's biodefense technology is an aggressive move towards giving our patients the peace of mind and security they need while seeking essential treatment at our hospitals," said Anthony Misitano, Chairman and CEO of PAM. "The COVID-19 pandemic has been disruptive for everyone and we see our proactive investment in this one-of-a-kind technology as just one of the many steps our organization has taken in our commitment to safety."

"In order to control the COVID-19 pandemic, the world needs to utilize science and technology to lead us out of this health crisis," said Dr. Garrett Peel, Founding Partner at IVP. "This invention by Monzer Hourani allows doctors and patients to breathe with confidence and focus on patient care."

About Post Acute Medical, LLC
PAM, based in Enola, Pennsylvania, provides post-acute health care services through more than 50 long-term acute care hospitals and medical rehabilitation hospitals, including several under development, as well as 18 outpatient physical therapy locations, in 13 states. PAM is committed to providing high-quality patient care and outstanding customer service, coupled with loyalty and dedication of highly trained staff, to be the most trusted source for post-acute services in every community it serves. Its mission is to serve people by providing compassionate, expert care and to support recovery through education and research. Learn more at

About Integrated Viral Protection (IVP)
Integrated Viral Protection (IVP) is a technology solutions company that specializes in the design of biodefense indoor air protection systems. Data from scientific peer reviewed publications show significant promise for reducing the transmission of the SARS-CoV-2 virus in the air, safeguarding people against the dangerous, life-threatening pathogen. IVP has formed a public/private partnership with a team of scientists, engineers, and virologists and has collaborated to develop a promising biodefense indoor air protection system that combats COVID-19, anthrax spores and other airborne pathogens in commercial, transportation, residential and personal environments. For more information, please visit:

SOURCE Post Acute Medical, LLC

Post Acute Medical has installed  IVP’s technology in three of its locations:

As a result of the effectiveness proven by IVP’s biodefense system, Post Acute Medical is adding the technology to locations in Corpus Christi, TX and Denver, CO.

After installing the biodefense system, Post Acute Medical confirmed with verified data that IVP’s technology improved air quality at all three facilities.

The IVP system kills more than 99% of airborne viruses and microbes

"This novel biodefense indoor air protection technology – endorsed by leading national and international scientists including Massachusetts Institute of Technology (MIT), Argonne National Laboratory amongst others – offers the first in line prevention against environmentally mediated transmission of airborne SARS-CoV-2 and will be on the forefront of the armamentarium of technologies available to combat current COVID-19 pandemic and any future airborne biothreats indoors," said Dr. Faisal Cheema, Associate Professor of Biomedical and Clinical Sciences at University of Houston College of Medicine.

In addition to Post Acute Medical, other companies and organizations have installed the biodefense system, including InterContinenal Hotel-Houston Medical Center, Texas A&M Health Science Center and Student Housing, the George R. Brown Convention Center in Houston, TX, True North Classical Academy in Miami, FL, and Slidell Independent School District in Slidell, TX

The patent-pending BIODEFENSE INDOOR AIR PROTECTION SYSTEM™ is FDA compliant with the enforcement policy for sterilizers, disinfectant devices, and air purifiers during the Coronavirus pandemic.

IVP’s biodefense technology is the result of breakthrough studies conducted at the Texas Center for Superconductivity at the University of Houston (TcSUH) & Galveston National Laboratory, the nation's premier facility for biodefense research. Endorsed by leading national and international scientists at MIT and Argonne National Laboratory, IVP’s biodefense system offers first in line prevention against environmental transmission of airborne SARS-CoV-2, the virus behind the COVID-19 pandemic, and any future airborne biothreats indoors. 

Want to learn more? Schedule an appointment with Post Acute Medical.